(Q35816412)

10 August 2017

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice (English)

1 reference

10 August 2017

Satoh J

1

1 reference

10 August 2017

Seino H

2

1 reference

10 August 2017

Abo T

3

1 reference

10 August 2017

Tanaka S

4

1 reference

10 August 2017

Shintani S

5

1 reference

10 August 2017

Ohta S

6

1 reference

10 August 2017

Tamura K

7

1 reference

10 August 2017

Sawai T

8

1 reference

10 August 2017

Nobunaga T

9

1 reference

10 August 2017

Oteki T

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

Journal of Clinical Investigation

10 August 2017

1 reference

10 August 2017

84

1 reference

10 August 2017

4

1 reference

10 August 2017

1345-1348

1 reference

Breeding of a non-obese, diabetic strain of mice

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Phase I study of recombinant tumor necrosis factor in cancer patients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Cachectin: more than a tumor necrosis factor

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Regulation of MHC protein expression in pancreatic beta-cells by interferon-gamma and tumor necrosis factor-alpha

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Cloning and expression in Escherichia coli of the gene for mouse tumor necrosis factor

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Preventive effects of cyclosporin on diabetes in NOD mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=329797

Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies

24 September 2018

1 reference

12 December 2020

Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide

1 reference

12 December 2020

The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction

1 reference

12 December 2020

IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans

1 reference

12 December 2020

In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432

1 reference

12 December 2020

Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice

1 reference

12 December 2020

Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation

1 reference

12 December 2020

Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent

1 reference

12 December 2020

Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice

1 reference

12 December 2020

Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses

1 reference

12 December 2020

HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin

1 reference

12 December 2020

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

1 reference

12 December 2020

Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice

1 reference

12 December 2020

Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice

1 reference

12 December 2020

Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells

1 reference

12 December 2020

Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice

1 reference

12 December 2020

Enhancement of in vivo immune response by tumor necrosis factor

1 reference

12 December 2020

Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1

1 reference

12 December 2020

Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity

1 reference

12 December 2020

Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI114304

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

2794065

1 reference